ORMP stock news · Oramed Pharmaceuticals Inc.
Get alerts for ORMP
Follow Oramed Pharmaceuticals Inc. (ORMP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ORMPFree on the App Store and Google Play, or on the web.
Oramed Pharmaceuticals is changing its rules to settle a class action lawsuit and avoid legal fees.
NeutralOramed reported a stockholder lawsuit was dismissed after it changed its bylaws and agreed to pay $125,000 in legal fees. The dispute does not change its outlook.
Oramed Pharmaceuticals Inc. asked its shareholders to vote on important issues.
NeutralOramed's annual meeting re-elected directors, ratified its auditor, and approved a 3,000,000-share increase to its equity incentive plan; these governance items do not change the company's outlook.